SCHEMBL20512258

SCHEMBL20512258

Cc1ccc(S(=O)(=O)NCCC#CC(O)c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 3/20 0.51
▸ LMNA P02545 3/20 0.51
▸ ALDH1A1 P00352 7/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ ATM Q13315 2/20 0.48
▸ CA12 O43570 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MAPT P10636 3/20 0.47
▸ USP2 O75604 1/20 0.47
▸ CYP19A1 P11511 1/20 0.46
▸ TP53 P04637 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20512253 0.88 ALDH1A1 (0.51) LMNAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL20512228 0.86 EGFR (0.45) NPSR1LMNAALDH1A1ATMMEN1
SCHEMBL20512235 0.85 CA1 (0.46) NPSR1LMNAALDH1A1MEN1KMT2A
SCHEMBL20512263 0.85 KMT2A (0.56) ALDH1A1CYP1A2CYP3A4CA12CA9
SCHEMBL20512261 0.83 CA12 (0.52) NPSR1LMNAALDH1A1CYP1A2CYP3A4
SCHEMBL20512274 0.82 CYP19A1 (0.43) NPSR1LMNAALDH1A1CYP1A2CYP3A4
SCHEMBL20512229 0.81 ALDH1A1 (0.53) NPSR1ALDH1A1CYP1A2CYP3A4ATM
SCHEMBL20512265 0.80 ALDH1A1 (0.50) LMNAALDH1A1CA12CA9MEN1
SCHEMBL20512232 0.79 ALDH1A1 (0.48) LMNAALDH1A1CA12CA9MEN1
SCHEMBL28529020 0.78 MMP2 (0.54) NPSR1LMNAALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180354963-A1 NOVEL LACTONES PURDUE RESEARCH FOUNDATION (US) 2018-12-13 — — US disclosed
US-10138252-B1 Lactones PURDUE RESEARCH FOUNDATION (US) 2018-11-27 — — US disclosed
US-20180305371-A1 NOVEL LACTONES PURDUE RESEARCH FOUNDATION (US) 2018-10-25 — — US disclosed
US-10087190-B1 Lactones PURDUE RESEARCH FOUNDATION (US) 2018-10-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180354963-A1 NOVEL LACTONES DHPS, FDPS, LSS NPSR1 3025/4885LMNA 4534/4885ALDH1A1 2443/4885
US-20180305371-A1 NOVEL LACTONES DHPS, FDPS, LSS NPSR1 3025/4885LMNA 4534/4885ALDH1A1 2443/4885
US-10138252-B1 Lactones DHPS, FDPS, LSS NPSR1 2701/4885LMNA 4466/4885ALDH1A1 2208/4885
US-10087190-B1 Lactones DHPS, FDPS, LSS NPSR1 2701/4885LMNA 4466/4885ALDH1A1 2208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback